Loading clinical trials...
Loading clinical trials...
A Pharmacogenetic Human Laboratory Investigation of Brexpiprazole in Alcohol Use Disorder
Conditions
Interventions
Brexpiprazole
Placebo
Locations
1
United States
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Start Date
October 30, 2020
Primary Completion Date
August 31, 2025
Completion Date
August 31, 2025
Last Updated
November 25, 2024
NCT05855668
NCT07071779
NCT07413458
NCT06939088
NCT06793488
NCT06648642
Lead Sponsor
University of Colorado, Denver
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions